|
|
Xingshen Sun, Hongshu Sui, John T. Fisher, Ziying Yan, Xiaoming Liu, Hyung-Ju Cho, Nam Soo Joo, Yulong Zhang, Weihong Zhou, Yaling Yi, Joann M. Kinyon, Diana C. Lei-Butters, Michelle A. Griffin, Paul Naumann, Meihui Luo, Jill Ascher, Kai Wang, Timothy Frana, Jeffrey J. Wine, David K. Meyerholz, John F. Engelhardt
J Clin Invest. 2010;
120(9):3149
doi:10.1172/JCI43052
Abstract |
Full text
| PDF
| Supplemental material

C
ystic fibrosis (CF) is a recessive disease that affects multiple organs. It is caused by mutations in CFTR. Animal modeling of this disease has been challenging, with species- and strain-specific differences in organ biology and CFTR function influencing the emergence of disease pathology. Here, we report the phenotype of a CFTR-knockout ferret model of CF. Neonatal CFTR-knockout ferrets demonstrated many of the characteristics of human CF disease, including defective airway chloride transport and submucosal gland fluid secretion; variably penetrant meconium ileus (MI); pancreatic, liver, and vas deferens disease; and a predisposition to lung infection in the early postnatal period. Severe malabsorption by the gastrointestinal (GI) tract was the primary cause of death in CFTR-knockout kits that escaped MI. Elevated liver function tests in CFTR-knockout kits were corrected by oral administration of ursodeoxycholic acid, and the addition of an oral proton-pump inhibitor improved weight gain and survival. To overcome the limitations imposed by the severe intestinal phenotype, we cloned 4 gut-corrected transgenic CFTR-knockout kits that expressed ferret CFTR specifically in the intestine. One clone passed feces normally and demonstrated no detectable ferret CFTR expression in the lung or liver. The animals described in this study are likely to be useful tools for dissecting CF disease pathogenesis and developing treatments.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(16)
| Title and authors |
Publication |
Year |
The AAV Vector Toolkit: Poised at the Clinical Crossroads
Aravind Asokan, David V Schaffer, R Jude Samulski
|
Mol Ther
|
2012 |
Advances in Cell and Gene-based Therapies for Cystic Fibrosis Lung Disease
Mayumi Oakland, Patrick L Sinn, Paul B McCray Jr
|
Mol Ther
|
2012 |
Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation
A Livraghi-Butrico, E J Kelly, E R Klem, H Dang, M C Wolfgang, R C Boucher, S H Randell, W K O'Neal
|
Mucosal Immunol
|
2012 |
Human cystic fibrosis airway epithelia have reduced Cl- conductance but not increased Na+ conductance
O. A. Itani, J.-H. Chen, P. H. Karp, S. Ernst, S. Keshavjee, K. Parekh, J. Klesney-Tait, J. Zabner, M. J. Welsh
|
Proceedings of the National Academy of Sciences
|
2011 |
The F508 Mutation Causes CFTR Misprocessing and Cystic Fibrosis-Like Disease in Pigs
L. S. Ostedgaard, D. K. Meyerholz, J.-H. Chen, A. A. Pezzulo, P. H. Karp, T. Rokhlina, S. E. Ernst, R. A. Hanfland, L. R. Reznikov, P. S. Ludwig, M. P. Rogan, G. J. Davis, C. L. Dohrn, C. Wohlford-Lenane, P. J. Taft, M. V. Rector, E. Hornick, B. S. Nassar, M. Samuel, Y. Zhang, S. S. Richter, A. Uc, J. Shilyansky, R. S. Prather, P. B. McCray, J. Zabner, M. J. Welsh, D. A. Stoltz
|
Science Translational Medicine
|
2011 |
Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease
Basma M Ibrahim, Michael D Tsifansky, Yan Yang, Yoon Yeo
|
Expert Opin. Drug Deliv.
|
2011 |
Genetic therapies for cystic fibrosis lung disease
P. L. Sinn, R. M. Anthony, P. B. McCray
|
Human Molecular Genetics
|
2011 |
CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice
Weiliang Xie, John T. Fisher, Thomas J. Lynch, Meihui Luo, Turan I.A. Evans, Traci L. Neff, Weihong Zhou, Yulong Zhang, Yi Ou, Nigel W. Bunnett, Andrew F. Russo, Michael J. Goodheart, Kalpaj R. Parekh, Xiaoming Liu, John F. Engelhardt
|
J. Clin. Invest.
|
2011 |
Therapeutics Development for Cystic Fibrosis: A Successful Model for a Multisystem Genetic Disease
Melissa A. Ashlock, Eric R. Olson
|
Annu. Rev. Med.
|
2011 |
Animal models of adrenocortical tumorigenesis
Felix Beuschlein, Sara Galac, David B. Wilson
|
Molecular and Cellular Endocrinology
|
2011 |
|